Department of Radiology

Publications

2018

Park M, Moon W-, Moon Y, Choi JW, Han S-, Wang Y. Region-specific susceptibility change in cognitively impaired patients with diabetes mellitus. PLoS One. 2018;13(10):e0205797.

Deh K, Ponath GD, Molvi Z, Parel G-, Gillen KM, Zhang S, et al. Magnetic susceptibility increases as diamagnetic molecules breakdown: Myelin digestion during multiple sclerosis lesion formation contributes to increase on QSM. J Magn Reson Imaging. 2018;48(5):1281-1287.

Zhang W, Tung C-. Real-Time Visualization of Lysosome Destruction Using a Photosensitive Toluidine Blue Nanogel. Chemistry. 2018;24(9):2089-2093.

Mosconi L, Walters M, Sterling J, Quinn C, McHugh P, Andrews RE, et al. Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer's disease: a cross-sectional study of middle-aged adults from the broader New York City area. BMJ Open. 2018;8(3):e019362.

Gillen KM, Mubarak M, Nguyen TD, Pitt D. Significance and Detection of Iron-Laden Microglia in White Matter Multiple Sclerosis Lesions. Front Immunol. 2018;9:255.

2017

Liu Z, Kee Y, Zhou D, Wang Y, Spincemaille P. Preconditioned total field inversion (TFI) method for quantitative susceptibility mapping. Magn Reson Med. 2017;78(1):303-315.

Kale SS, Burga RA, Sweeney EE, Zun Z, Sze RW, Tuesca A, et al. Composite iron oxide-Prussian blue nanoparticles for magnetically guided T-weighted magnetic resonance imaging and photothermal therapy of tumors. Int J Nanomedicine. 2017;12:6413-6424.

Razlighi QR, Habeck C, Barulli D, Stern Y. Cognitive neuroscience neuroimaging repository for the adult lifespan. Neuroimage. 2017;144(Pt B):294-298.

Ostenson J, Pujara AC, Mikheev A, Moy L, Kim SG, Melsaether AN, et al. Voxelwise analysis of simultaneously acquired and spatially correlated F-fluorodeoxyglucose (FDG)-PET and intravoxel incoherent motion metrics in breast cancer. Magn Reson Med. 2017;78(3):1147-1156.

Galla N, Chiang G, Chakraborty S, Singh R, A Tsiouris J, Boockvar J, et al. Apparent diffusion coefficient changes predict survival after intra-arterial bevacizumab treatment in recurrent glioblastoma. Neuroradiology. 2017;59(5):499-505.